Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Now if we only knew what is in the memorandum of understanding

And that squares with:

“all the information contained in our April 9, 2008 earnings release, which fully reflects the financial results of all transactions announced prior to the end of January 2008.”

http://patriotscientific.com/index.php?option=com_content&task=view&id=168&Itemid=29

and

“While I understand the on-going disappointment of the shareholders who held high expectations for the J3 negotiations…”

http://patriotscientific.com/index.php?option=com_content&task=view&id=174&Itemid=29

Not to mention FASB accounting for contingencies.

Interesting, I await the outcome, and obviously GLTAL.

Share
New Message
Please login to post a reply